ARVN Competitors & Alternatives
Compare Arvinas Inc with similar stocks in the same industry
Biotechnology
ARVN
Main Stock$7.72
Tradestie Score
60
Market Cap
$670.30M
P/E Ratio
29.1
Revenue Growth
10.1%
Analyst Upside
+80.4%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.49
|
$512.39M | - | 65 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$48.86
|
$505.12M | 2.8 | 56 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$97.10
|
$492.21M | - | 65 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$9.37
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$11.11
|
$463.20M | - | 45 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$6.19
|
$457.09M | - | 57 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.07
|
$454.29M | - | 56 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$12.34
|
$448.32M | - | 44 | Compare |
More ARVN Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry